Anlotinib Combined With Chemotherapy for Recurrence of Pulmonary Sarcomatoid Cancer Previously Surgically Treated: A Case Report and Literature Review

BackgroundPulmonary sarcomatoid cancer (PSC) is a very rare subtype of poorly differentiated non-small-lung-cancer (NSCLC) with very poor prognosis. To date, the optimal treatment for PSC has not been elucidated, and the efficacy of anlotinib in PSC has not been previously reported.Case Presentation...

Full description

Bibliographic Details

Published in:	Frontiers in Oncology
Main Authors:	Jing Li, Hejun Liang, Jian He, Xin Sui, Yanru Qin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-05-01
Subjects:	pulmonary sarcomatoid cancer (PSC) anlotinib chemotherapy targeted therapy case report
Online Access:	https://www.frontiersin.org/articles/10.3389/fonc.2021.639168/full